Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab)) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating dupilumab versus placebo in adults with moderately to severely active ulcerative colitis with an eosinophilic phenotype; currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Colitis Ulcerative | Phase 2 | Status: ACTIVE_NOT_RECRUITING